Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 30fludarabine phosphate 13Etoposide 12Cyclophosphamide 11Mitoxantrone 10Peripheral Blood Stem Cell Transplantation 9Decitabine 9Tacrolimus 7Filgrastim 7Mycophenolic Acid 6Bortezomib 6Idarubicin 5Flow Cytometry 5Daunorubicin 5Antilymphocyte Serum 5tipifarnib 4sargramostim 4Whole-Body Irradiation 4Vorinostat 4Radiotherapy 4Cyclosporine 4Cord Blood Stem Cell Transplantation 4Clofarabine 4Busulfan 4alvocidib 3Polymerase Chain Reaction 3Melphalan 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3tanespimycin 2selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Congenital Abnormalities × choline magnesium trisalicylate × Clear all
NCT00156299 2013-11-19

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Rutgers, The State University of New Jersey

Phase 1 Terminated
15 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡